This study reveals the mechanism by which THBS1 drives adipose tissue fibrosis in obesity and type 2 diabetes through activation of the TGF-β pathway. It provides a clear experimental design framework for screening drug targets and constructing gene knockout mouse models for related metabolic disorders.
Literature Overview
The article titled "Single-cell landscape of human adipose tissue reveals THBS1 as a potential driver of fibro-inflammation in metabolic disease," published in Nature Communications, systematically explores the single-cell landscape of human visceral adipose tissue across different metabolic states, identifying THBS1 as a key molecular driver of adipose fibro-inflammation. By integrating single-nucleus transcriptomics with functional validation experiments, the study elucidates how aberrant THBS1 expression in adipose stem cells and mature adipocytes leads to metabolic dysfunction.Background Knowledge
Dysfunction of adipose tissue is a core pathological feature of metabolic diseases such as obesity and type 2 diabetes; however, significant bottlenecks remain in understanding its cellular heterogeneity and molecular mechanisms. In particular, fibrotic remodeling and chronic inflammation within adipose tissue often lead to insulin resistance and systemic metabolic disorders, yet the specific driving factors remain unclear. As an extracellular matrix protein, THBS1 is known to participate in tissue repair and inflammatory responses, but its specific mechanisms of action and cellular origins within the adipose tissue microenvironment have lacked in-depth analysis. This study leverages high-resolution single-cell sequencing technology combined with rigorous stratification of metabolic states (lean, obese, and obese with diabetes) to precisely locate specific cell subpopulations expressing THBS1. It aims to解析 the intercellular communication network mediated by the TGF-β signaling pathway, thereby bridging the gap between cellular atlas mapping and functional mechanism elucidation.
Research Methods and Core Experiments
The authors constructed a cohort comprising lean, simple obese, and obese individuals with type 2 diabetes, utilizing single-nucleus RNA sequencing (snRNA-seq) and bulk RNA-seq to map the detailed cellular landscape of human visceral adipose tissue. The study focused on analyzing the subpopulation heterogeneity of adipose stem cells (ASCs) and adipocytes, validating key findings through flow cytometry, immunofluorescence staining, and in vitro co-culture systems. To elucidate the mechanism, the team employed strategies including recombinant THBS1 protein treatment, THBS1 gene knockdown (shRNA), and neutralizing antibody blockade, conducting gain-of-function and loss-of-function experiments in both in vitro cell models (human primary ASCs, THP-1 macrophages, Matrigel-embedded mature adipocytes) and in vivo mouse models.
Key evidence showed that ASC and adipocyte subpopulations with high THBS1 expression were significantly enriched in patients with metabolic diseases. In vitro experiments confirmed that exogenous THBS1 directly inhibits adipogenesis and promotes the expression of fibrosis markers. Further co-culture experiments revealed that THBS1 activates macrophage secretion of TGF-β, which subsequently induces the transformation of adipose stem cells into fibroblasts via a paracrine mechanism, creating a vicious cycle of fibro-inflammation. In vivo experiments demonstrated that neutralizing antibodies blocking THBS1 or inhibiting TGF-β receptor signaling effectively reversed adipose fibrosis characteristics and improved metabolic indicators.Key Conclusions and Perspectives
Research Significance and Prospects
This discovery provides a highly promising new target for drug development, particularly monoclonal antibodies or small molecule inhibitors against THBS1, which could become effective means to reverse adipose fibrosis. In terms of clinical monitoring, THBS1 is expected to serve as a novel biomarker for assessing the progression of metabolic diseases and the degree of fibrosis. Furthermore, the specific cell subpopulation atlas and functional validation models established in this study offer important references for disease modeling, aiding in the construction of more precise animal models for obesity and type 2 diabetes to screen candidate drugs.
Conclusion
Through high-precision single-cell atlas analysis, this study successfully identified THBS1 as the key hub connecting adipose tissue inflammation and fibrosis. From basic mechanistic exploration in the laboratory to preliminary validation for clinical translation, this research not only elucidates the deep molecular mechanisms of adipose tissue dysfunction in obesity and type 2 diabetes but also points the way for future diagnostic and therapeutic strategies. By targeting the THBS1 and its downstream TGF-β signaling axis, it is possible to break the pathological cycle of adipose fibrosis, improve insulin resistance, and provide more targeted treatment options for patients with metabolic diseases. This finding plays a foundational role in building a complete translational medicine system from molecular mechanisms to clinical applications, marking a significant step forward in our understanding of the complex microenvironment of metabolic diseases.
